Corcept Therapeutics | CORT - 普通股股本



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.92B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


普通股股本 更改 日
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Alaunos Therapeutics USD 2.38M 172K 2026-03
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Ardelyx USD 246.97M 2.62M 2026-03
Aurora Cannabis CAD 58.95M 2.24M 2026-03
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
J&J USD 2.41B 1.35M 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Merck USD 2.47B 4.93M 2026-03
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Omeros USD 611K 17K 2023-12
Pacira USD 39.82M 512K 2026-06
Pfizer USD 5.7B 0 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06